Bellicum Pharmaceuticals Inc

NASDAQ:BLCM   12:56:33 PM EDT
3.08
-0.13 (-4.05%)
Earnings Announcements

Bellicum Reports Q1 Results

Published: 05/17/2021 11:53 GMT
Bellicum Pharmaceuticals Inc (BLCM) - Bellicum Pharmaceuticals Inc - Expects That Current Cash Resources Will Be Sufficient to Meet Operating Requirements Into Q2 of 2022.
Bellicum Pharmaceuticals Inc - Reported a Net Loss of $11.3 Million for Q1 of 2021 Compared to Net Income of $17.6 Million for Comparable Period in 2020.
Revenue is expected to be $0.3 Million
Adjusted EPS is expected to be -$0.85

Next Quarter Revenue Guidance is expected to be $0.3 Million
Next Quarter EPS Guidance is expected to be -$0.85

More details on our Analysts Page.